HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The impact of standard high-flux polysulfone versus novel high-flux polysulfone dialysis membranes on inflammatory markers: a randomized, single-blinded, controlled clinical trial.

AbstractBACKGROUND:
This study is a prospective, randomized, single-blind, clinical trial over 12 months involving 60 stable hemodialysis patients comparing standard high-flux polysulfone dialyzer membranes with a novel high-flux polysulfone dialyzer membrane (Helixone; Fresenius Medical Care, St Wendel, Germany) modified in the fiber-spinning process to enhance middle-molecule clearance through changing the distribution of pore size and increased filtration.
METHODS:
Markers of protein and lipid oxidation and inflammatory markers, including proinflammatory cytokines and cell adhesion molecules, were compared. The hypothesis tested was that improved clearances of middle molecules with the FX80 membrane would lead to less oxidative stress and inflammation compared with the high-flux polysulfone (HF80) membrane.
RESULTS:
Type of dialysis membrane used did not significantly affect lipid and protein peroxidation, C-reactive protein level, interleukin 6 level, or sgp130 level during 12 months. beta(2)-Microglobulin concentrations decreased significantly in the Helixone membrane group compared with those dialyzed using conventional polysulfone membranes during the study (-15%; 95% confidence interval, -20 to -10).
CONCLUSION:
Long-term dialysis with a Helixone membrane did not modify any parameters of oxidative stress or inflammation in this stable hemodialysis population compared with a high-flux polysulfone dialysis membrane.
AuthorsPeter G Kerr, Wayne H F Sutherland, Sylvia de Jong, Indran Vaithalingham, Sheila M Williams, Robert J Walker
JournalAmerican journal of kidney diseases : the official journal of the National Kidney Foundation (Am J Kidney Dis) Vol. 49 Issue 4 Pg. 533-9 (Apr 2007) ISSN: 1523-6838 [Electronic] United States
PMID17386321 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers
  • Interleukin-6
  • Membranes, Artificial
  • Polymers
  • Proteins
  • Sulfones
  • beta 2-Microglobulin
  • Cytokine Receptor gp130
  • polysulfone P 1700
  • C-Reactive Protein
Topics
  • Adult
  • Aged
  • Biomarkers (blood)
  • C-Reactive Protein (metabolism)
  • Cytokine Receptor gp130 (blood)
  • Equipment Design
  • Female
  • Humans
  • Inflammation (blood)
  • Interleukin-6 (blood)
  • Lipid Peroxidation
  • Male
  • Membranes, Artificial
  • Middle Aged
  • Oxidation-Reduction
  • Oxidative Stress
  • Polymers
  • Proteins (metabolism)
  • Renal Dialysis (instrumentation)
  • Single-Blind Method
  • Sulfones
  • Time Factors
  • beta 2-Microglobulin (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: